MyFinsight
Home
Blog
About
Contact
Back
Cash Flow
Cocrystal Pharma, Inc. (COCP)
Cocrystal Pharma, Inc. (COCP)
source: myfinsight.com
Download
Download image
Net decrease in cash
and restricted cash
-$2,340K
Operating lease
liabilities
$142K
Stock-based compensation
$84K
Tax credit
receivable
-$15K
Depreciation and
amortization expense
$12K
Accounts payable and
accrued expenses
$10K
Net cash used in
operating activities
-$2,340K
Canceled cashflow
$263K
Net loss
-$2,299K
Decrease right of use
assets
-$147K
Prepaid expenses and
other current assets
$90K
Grant receivable
$70K
Back